Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -431.19%-36.85K | -696.70%-561.57K | 2.57%-187.21K | 55.19%-439.41K | 16.43%-187.91K | 108.58%11.13K | 87.78%-70.49K | -288.18%-192.15K | -36.47%-980.68K | -6,606.37%-224.86K |
| Net income from continuing operations | -836.23%-655.39K | -17.01%-315.73K | 5.33%-198.33K | 37.90%-1.03M | -6.17%-481.76K | 71.52%-70K | 54.91%-269.83K | 42.17%-209.51K | -47.21%-1.66M | -6.96%-453.76K |
| Depreciation and amortization | 3,691.12%44.89K | --0 | --0 | -51.55%3.5K | 187.68%2.8K | -228.21%-1.25K | 0.00%975 | -77.35%975 | -83.56%7.23K | -97.75%974 |
| Asset impairment expenditure | --0 | --0 | --0 | 29.52%110.42K | -38.29%49.05K | --0 | 30,657.14%60.28K | -77.39%1.09K | 136.06%85.25K | 120.09%79.48K |
| Remuneration paid in stock | --0 | --0 | --0 | -68.61%108.89K | -103.06%-2.06K | -35.34%35.47K | -81.75%40.98K | --34.5K | 353.77%346.9K | --67.49K |
| Change In working capital | 1,122.86%573.65K | -353.19%-245.84K | 157.91%11.12K | 53.55%368.87K | 201.48%244.06K | -21.12%46.91K | 147.63%97.1K | -106.32%-19.2K | -6.05%240.23K | -76.95%80.96K |
| -Change in receivables | ---11.83K | -268.42%-14.42K | -781.78%-4.83K | -118.16%-9.32K | -142.41%-18.58K | --0 | 109.04%8.56K | 103.62%708 | 207.22%51.31K | 822.42%43.82K |
| -Change in inventory | ---- | --0 | --0 | 67.03%-5.53K | -1,771.00%-5.53K | -74.60%1.6K | --0 | 95.43%-1.6K | 79.48%-16.77K | -99.71%331 |
| -Change in prepaid assets | -2,427.03%-23.25K | 74.52%8.67K | -703.99%-30K | -100.75%-1.2K | -350.29%-12.13K | 107.40%999 | -9.97%4.97K | -96.96%4.97K | -22.84%160.03K | -97.97%4.85K |
| -Change in payables and accrued expense | 1,273.73%608.73K | -387.30%-240.09K | 297.40%45.95K | 742.90%384.91K | 776.95%280.31K | 180.39%44.31K | 166.18%83.57K | -111.93%-23.28K | -74.33%45.67K | 504.58%31.96K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -431.19%-36.85K | -696.70%-561.57K | 2.57%-187.21K | 55.19%-439.41K | 16.43%-187.91K | 108.58%11.13K | 87.78%-70.49K | -288.18%-192.15K | -36.47%-980.68K | -6,606.37%-224.86K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -443.02K | 0 | ||||||||
| Net business purchase and sale | ---443.02K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---443.02K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.16M | 724.74K | 23.02%258.4K | -44.81%527.86K | 241.75%317.81K | 0 | 0 | 200.07%210.05K | 72,552.58%956.37K | 453.33%93K |
| Net issuance payments of debt | --16.86K | ---20.26K | --3.4K | --17.83K | --17.83K | --0 | --0 | --0 | --0 | ---- |
| Net common stock issuance | ---475K | ---- | ---- | -33.33%510.04K | --299.99K | --0 | ---- | ---- | 5,000.00%765K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 320.00%126K | --0 |
| Net other financing activities | ---- | ---- | 21.40%255K | ---- | ---- | ---- | ---- | --210.05K | --65.37K | --93K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --2.16M | --724.74K | 23.02%258.4K | -44.81%527.86K | 241.75%317.81K | --0 | --0 | 200.07%210.05K | 72,552.58%956.37K | 453.33%93K |
| Net cash flow | ||||||||||
| Beginning cash position | 15,541.90%144.85K | 203.78%211.28K | 171.27%140.09K | -32.00%51.64K | -94.45%10.19K | -100.36%-938 | -27.89%69.55K | -32.00%51.64K | -90.60%75.95K | 77.62%183.51K |
| Current changes in cash | 14,973.79%1.68M | 5.75%-66.43K | 297.56%71.18K | 463.88%88.45K | 198.52%129.91K | 113.96%11.13K | -142.27%-70.49K | -12.66%17.91K | 96.66%-24.31K | -476.73%-131.86K |
| End cash Position | 17,783.62%1.82M | 15,541.90%144.85K | 203.78%211.28K | 171.27%140.09K | 171.27%140.09K | -94.45%10.19K | -100.36%-938 | -27.89%69.55K | -32.00%51.64K | -32.00%51.64K |
| Free cash from | -431.19%-36.85K | -696.70%-561.57K | 2.57%-187.21K | 55.19%-439.41K | 16.43%-187.91K | 108.58%11.13K | 87.78%-70.49K | -288.18%-192.15K | -35.12%-980.68K | -6,606.37%-224.86K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.